Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MicroRNAs (miRNAs) regulate gene expression and are implicated in various cancers.
• Let-7, an early discovered miRNA, is known as a tumor suppressor in many solid tumors.
• The specific role of let-7a in breast cancer progression and its molecular targets remain incompletely understood.

Purpose of the Study:

• To investigate the expression and function of let-7a in breast cancer.
• To identify and validate the target genes of let-7a in breast cancer.
• To explore the potential of let-7a as a therapeutic target for breast cancer.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess let-7a and MAGE-A1 expression.
• In vitro cell culture experiments to evaluate let-7a's effect on cell proliferation, migration, and invasion.
• Dual-luciferase reporter assays to confirm MAGE-A1 as a direct target of let-7a.
• Western blot analysis to examine MAGE-A1 protein levels.

Main Results:

• Let-7a expression inversely correlated with tumor size, histological grade, Her-2 positivity, and high Ki-67 index.
• Melanoma-associated antigen A1 (MAGE-A1) was identified as a direct target of let-7a, with expression inversely correlating with let-7a levels.
• Let-7a significantly inhibited breast cancer cell proliferation, migration, and invasion in vitro.
• Let-7a suppressed MAGE-A1 expression at both mRNA and protein levels.

Conclusions:

• Let-7a functions as a tumor suppressor in breast cancer by directly targeting and inhibiting MAGE-A1.
• Reduced let-7a expression is associated with more aggressive breast cancer phenotypes.
• Targeting the let-7a/MAGE-A1 axis presents a promising novel therapeutic strategy for breast cancer treatment.